Targeting growth factor receptors with fusion toxins.

[1]  F. Studier,et al.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.

[2]  D. Mckay,et al.  Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Ozanne,et al.  Human squamous cell lung cancers express increased epidermal growth factor receptors. , 1984, The Journal of clinical investigation.

[4]  R. Reynolds,et al.  Characterization of epidermal growth factor receptor in normal and neoplastic human endometrium , 1990, Cancer.

[5]  I. Pastan,et al.  Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain. , 1988, The Journal of biological chemistry.

[6]  I. Pastan,et al.  A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  L. Ghosh,et al.  Epidermal growth factor in the normal and neoplastic kidney and bladder. , 1988, The Journal of urology.

[8]  T. Waldmann,et al.  IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes. , 1990, The Journal of biological chemistry.

[9]  T. Waldmann,et al.  A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin , 1989, Nature.

[10]  T. Hirano,et al.  TETSUYA TAGA , YOSHIKAZU KAWANISHI , 2003 .

[11]  M. Gregoriou,et al.  Epidermal growth factor receptor expression in 72 meningiomas , 1990, Cancer.

[12]  J. Case,et al.  Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  I. Pastan,et al.  Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. , 1990, Cancer research.

[14]  T. Waldmann,et al.  The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  I. Pastan,et al.  Cytotoxic activities of a fusion protein comprised of TGFα and Pseudomonas exotoxin , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  I. Pastan,et al.  Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. , 1991, The Journal of biological chemistry.

[17]  G. Paludetti,et al.  Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors , 1991, Cancer.

[18]  I. Pastan,et al.  Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels. , 1990, The Journal of biological chemistry.

[19]  I. Pastan,et al.  Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Asaoku,et al.  Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas , 1988, Nature.

[21]  I. Pastan,et al.  Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Gelmann,et al.  Role of transforming growth factor ‐α in human prostate cancer cell growth , 1989 .

[23]  I. Pastan,et al.  IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptors. , 1988, Journal of immunology.

[24]  D. Heimbrook,et al.  Epidermal growth factor receptor binding is affected by structural determinants in the toxin domain of transforming growth factor-alpha-Pseudomonas exotoxin fusion proteins , 1989, Molecular and cellular biology.

[25]  I. Pastan,et al.  Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40). , 1991, Cancer research.

[26]  I. Pastan,et al.  Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol. , 1990, The Journal of biological chemistry.

[27]  M. Melamed,et al.  Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. , 1986, Cancer research.

[28]  I. Pastan,et al.  Pseudomonas exotoxin: chimeric toxins. , 1989, The Journal of biological chemistry.

[29]  I. Pastan,et al.  Mutagenesis of Pseudomonas exotoxin in identification of sequences responsible for the animal toxicity. , 1990, The Journal of biological chemistry.

[30]  I. Pastan,et al.  Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli , 1987, Cell.

[31]  I. Pastan,et al.  Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[32]  I. Pastan,et al.  Cytotoxic activity of a recombinant fusion protein between insulin-like growth factor I and Pseudomonas exotoxin. , 1991, Cancer Research.

[33]  I. Pastan,et al.  Cardiac allograft survival in mice treated with IL-2-PE40. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  I. Pastan,et al.  Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice. , 1991, Cancer research.

[35]  W. Greene,et al.  Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen , 1984, The Journal of experimental medicine.

[36]  J. Bauer,et al.  Regulation of interleukin‐6 receptor expression in human monocytes and hepatocytes , 1989, FEBS letters.

[37]  I. Pastan,et al.  Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  I. Pastan,et al.  Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin. , 1989, The Journal of biological chemistry.

[39]  I. Pastan,et al.  Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Waldmann,et al.  Interleukin 2 (IL2) PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL2 receptor. , 1988, The Journal of biological chemistry.

[41]  J. Case,et al.  Administration of IL-2-PE40 via osmotic pumps prevents adjuvant induced arthritis in rats. Improved therapeutic index of IL-2-PE40 administered by continuous infusion. , 1991, International journal of immunopharmacology.

[42]  I. Pastan,et al.  Cell-Specific Toxicity of a Chimeric Protein Composed of Interleukin-6 and Pseudomonas Exotoxin (IL6-PE40) on Tumor Cells , 1990, Molecular and cellular biology.

[43]  I. Pastan,et al.  Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells. , 1990, The Journal of biological chemistry.

[44]  I. Pastan,et al.  Cytotoxic activity of chimeric proteins composed of acidic fibroblast growth factor and Pseudomonas exotoxin on a variety of cell types , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  T. Waldmann,et al.  Pseudomonas exotoxin-anti-TAC. Cell-specific immunotoxin active against cells expressing the human T cell growth factor receptor. , 1984, The Journal of clinical investigation.